Updated:
Linden Capital Partners
Linden Capital Partners is an SEC-registered investment adviser in Chicago, IL, registered since 2012. The firm manages approximately $13.9 billion in assets.
Linden Capital Partners
Linden Capital Partners is an SEC-registered investment adviser in Chicago, IL, registered since 2012. The firm manages approximately $13.9 billion in assets. It has 55 employees and 47 investment advisers.
General information
Firm type
Private Equity
Year founded
2006
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Chicago
Corporate office
Chicago, IL, United States
Sector focus
Frequently asked questions
What does Linden Capital Partners invest in?
Linden is a sector-concentrated private equity firm focused on middle-market healthcare and life sciences companies. The firm targets buyouts, management buyouts, growth equity, recapitalizations, and corporate divestitures within that vertical. Its portfolio includes medical device companies such as Regenity Biosciences (per the firm, February 2026).
Does Linden Capital Partners invest outside of healthcare?
No. Linden's public disclosures and website framing indicate an exclusive focus on healthcare and life sciences. There are no documented investments in other sectors.
How does Linden Capital Partners structure its deals?
Linden deploys capital through buyouts, management buyouts, growth equity, recapitalizations, and public-to-private transactions. The firm also executes complex situations such as corporate divestitures and restructurings, all within its healthcare mandate.
Does Linden Capital Partners co-invest with other firms?
Yes. In February 2026, Linden brought in Cinven as a strategic co-investor in portfolio company Regenity Biosciences while retaining its own position (per the firm, February 2026). This indicates openness to partnering with other private equity firms on specific assets.
What is Linden Capital Partners' Value Creation Program?
The firm references a proprietary 'Value Creation Program' on its website, positioning it as a differentiating operational framework. Specific details of the program — such as dedicated operating partners, playbook components, or performance metrics — are not publicly disclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: